The role of platelets and megakaryocytes in sepsis and ARDS
The Journal of Physiology · 2024-11 · 602 (22) · 6047-6063
DOI: 10.1113/jp284879 ↗At a glance
Übersichtsarbeit in The Journal of Physiology, published online on 2024-10-19. Written by Gabriel Leung and 1 co-authors. Institution: Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA. Major MEDLINE topics: Megakaryocytes, Sepsis, Respiratory Distress Syndrome, Blood Platelets. Cited 21 times so far (Crossref); 126 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NHLBI NIH HHS.
Topics: Sepsis
Abstract (original language)
Since the global COVID‐19 pandemic, there has been a renewed focus on lung injury during infection. Systemic inflammatory responses such as acute respiratory distress syndrome (ARDS) and sepsis are a leading cause of morbidity and mortality for both adults and children. Improvements in clinical care have improved outcomes but mortality remains ∼40% and significant morbidity persists for those patients with severe disease. Mechanistic studies of the underlying biological processes remain essential to identifying therapeutic targets. Furthermore, methods for identifying the underlying drivers of organ failure are key to treating and preventing tissue injury. In this review, we discuss the contribution of megakaryocytes (MKs) and platelets to the pathogenesis of systemic inflammatory syndromes. We explore the role of MKs and the new identification of extramedullary MKs during sepsis. We describe the alterations in the platelet transcriptome during sepsis. Lastly, we explore platelet function as defined by aggregation, activation and the formation of heterotypic aggregates. Much more work is necessary to explore the contribution of platelets to these heterogenous syndromes, but the foundation of platelets as key contributors to inflammation has been laid. image
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Division of Pulmonary, Department of Internal Medicine, University of Utah, Salt Lake City, Utah, USA.
- Molecular Medicine Program, University of Utah, Salt Lake City, Utah, USA.
ORCID profiles: Elizabeth A Middleton
Funding
- NHLBI NIH HHS
Cite
APA
Leung, G., & Middleton, E. A. (2024). The role of platelets and megakaryocytes in sepsis and ARDS. The Journal of Physiology, 602(22), 6047-6063. https://doi.org/10.1113/jp284879
Vancouver
Leung G, Middleton EA. The role of platelets and megakaryocytes in sepsis and ARDS. The Journal of Physiology. 2024;602(22):6047-6063. doi:10.1113/jp284879
BibTeX
@article{Leung2024,
author = {Leung, Gabriel and Middleton, Elizabeth A},
title = {The role of platelets and megakaryocytes in sepsis and ARDS},
journal = {The Journal of Physiology},
year = {2024},
volume = {602},
number = {22},
pages = {6047--6063},
doi = {10.1113/jp284879}
}
EUVIMED